Global Bacille Calmette-Guerin Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Bacille Calmette-Guerin Vaccine market size was valued at US$ 80.4 million in 2024 and is forecast to a readjusted size of USD 99 million by 2031 with a CAGR of 3.0% during review period.

The Bacille Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). Developed from a strain of weakened Mycobacterium bovis, the BCG vaccine is commonly administered to infants and children in countries where tuberculosis is prevalent. While it does not provide complete immunity, it significantly reduces the risk of severe forms of TB, such as TB meningitis and miliary tuberculosis in young children. BCG is also being researched for potential applications in treating bladder cancer and boosting immune responses in certain conditions.

The primary drivers of the Bacille Calmette-Guérin (BCG) vaccine market is the continued high prevalence of tuberculosis (TB) in many parts of the world, particularly in Asia and Africa. Increased awareness and government initiatives to control and eradicate TB contribute to demand for the vaccine. Additionally, ongoing research on the potential use of the BCG vaccine in treating other diseases, such as bladder cancer and potentially as a non-specific immune booster, is also bolstering its market demand.

A major challenge in the BCG vaccine market is supply constraints due to the limited number of manufacturers, as production requires specialized facilities and quality control measures. Additionally, the vaccine's effectiveness varies by region and is less protective in adults than in children, which affects its perception and demand in some areas. Furthermore, stringent regulatory standards and the relatively long time required for production can limit supply, especially during times of increased demand or global health crises. Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 36%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, etc. are the leaders of the industry.

This report is a detailed and comprehensive analysis for global Bacille Calmette-Guerin Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Bacille Calmette-Guerin Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031

Global Bacille Calmette-Guerin Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031

Global Bacille Calmette-Guerin Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031

Global Bacille Calmette-Guerin Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Bacille Calmette-Guerin Vaccine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Bacille Calmette-Guerin Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Bacille Calmette-Guerin Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Immune Vaccine
Therapy Vaccine

Market segment by Application
Self-Procurement
UNICEF
Other

Major players covered
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Bacille Calmette-Guerin Vaccine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Bacille Calmette-Guerin Vaccine, with price, sales quantity, revenue, and global market share of Bacille Calmette-Guerin Vaccine from 2020 to 2025.

Chapter 3, the Bacille Calmette-Guerin Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Bacille Calmette-Guerin Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bacille Calmette-Guerin Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Bacille Calmette-Guerin Vaccine.

Chapter 14 and 15, to describe Bacille Calmette-Guerin Vaccine sales channel, distributors, customers, research findings and conclusion.